Top

Clinical Oral Investigations

Published in:

01-04-2016 | Original Article

In vitro activity of taurolidine gel on bacteria associated with periodontitis

Authors: Sigrun Eick, Nicoletta Gloor, Cecilia Püls, Jürg Zumbrunn, Anton Sculean

Published in: Clinical Oral Investigations | Issue 3/2016

Abstract

Objectives

The purpose of this in vitro study was to determine the antimicrobial activity of two different taurolidine gel formulations in comparison with minocycline microspheres.

Methods

Three percent taurolidine gel (TLG3) and 2 % taurolidine gel (TLG2) were compared to minocycline microspheres (MINO) against single bacterial species and a 12-species-mixture. The antimicrobial activity was proven by determination of minimal inhibitory concentrations (MICs), killing assays, after exposure of the antimicrobials as well as within a biofilm.

Results

The MICs against the single species were between 0.5 and 2 mg/ml of taurolidine. MICs of the used mixed microbiota were 1.5 mg/ml (TLG3) and 4 mg/ml (TLG2). Fusobacterium nucleatum and Porphyromonas gingivalis were completely killed by 10 % TLG3 and TLG2 (equivalent to 3 and 2 mg/ml taurolidine) after 6 h. The mixture of 12 species was not completely killed by any of the test substances. Taurolidine gels showed a post-antimicrobial activity, however being less than that of MINO. On biofilms, taurolidine gels reduced concentration dependently the colony forming unit (CFU) counts (multi-species biofilms by 3.63 log10 after 100 % (30 mg/ml) of TLG3), reductions were 2.12 log10 after MINO (1000 μg/ml minocycline).

Conclusions

Taurolidine gel formulations exert antimicrobial activity against bacteria associated with periodontal disease. Nevertheless, a complete elimination of biofilms seems to be impossible and underlines the importance of mechanical removal of biofilms prior to application of the antimicrobial.

Clinical relevance

Taurolidine gels may represent a potential alternative for adjunctive topical antimicrobial treatment in periodontitis and infectious peri-implant diseases.

Gidley MJ, Sanders JK, Myers ER, Allwood MC (1981) The mode of antibacterial action of some ‘masked’ formaldehyde compounds. FEBS Lett 127:225–227CrossRefPubMed

Caruso F, Darnowski JW, Opazo C, Goldberg A, Kishore N, Agoston ES, Rossi M (2010) Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PLoS One 5:e8927CrossRefPubMedPubMedCentral

Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202CrossRefPubMed

Linder MM, Ott W, Wesch G, Wicki O, Marti MC, Moser G (1981) Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author’s transl). Langenbecks Arch Chir 353:241–250CrossRefPubMed

Arweiler NB, Auschill TM, Sculean A (2012) Antibacterial effect of taurolidine (2%) on established dental plaque biofilm. Clin Oral Investig 16:499–504CrossRefPubMed

John G, Schwarz F, Becker J (2015) Taurolidine as an effective and biocompatible additive for plaque-removing techniques on implant surfaces. Clin Oral Investig 19:1069–1077CrossRefPubMed

John G, Becker J, Schwarz F (2014) Effects of taurolidine and chlorhexidine on SaOS-2 cells and human gingival fibroblasts grown on implant surfaces. Int J Oral Maxillofac Implants 29:728–734CrossRefPubMed

Eick S, Radakovic S, Pfister W, Nietzsche S, Sculean A (2012) Efficacy of taurolidine against periodontopathic species—an in vitro study. Clin Oral Investig 16:735–744CrossRefPubMed

Reynolds S, Moran J, Addy M, Wade WG, Newcombe R (1991) Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo. Clin Prev Dent 13:13–17PubMed

10.

Blenkharn JI (1990) In-vitro antibacterial activity of noxythiolin and taurolidine. J Pharm Pharmacol 42:589–590CrossRefPubMed

11.

Tew JG, Marshall DR, Burmeister JA, Ranney RR (1985) Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis. Infect Immun 49:487–493PubMedPubMedCentral

12.

Zollinger L, Schnyder S, Nietzsche S, Sculean A, Eick S (2015) In-vitro activity of taurolidine on single species and a multispecies population associated with periodontitis. Anaerobe 32:18–23CrossRefPubMed

13.

Goodson JM (2003) Gingival crevice fluid flow. Periodontol 2000(31):43–54CrossRef

14.

Pradeep AR, Sagar SV, Daisy H (2008) Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis. J Periodontol 79:2125–2135CrossRefPubMed

15.

Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S (1998) The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 69:1085–1091CrossRefPubMed

16.

Van Dyke TE, Offenbacher S, Braswell L, Lessem J (2002) Enhancing the value of scaling and root-planing: arestin clinical trial results. J Int Acad Periodontol 4:72–76PubMed

17.

Kim TS, Burklin T, Schacher B, Ratka-Kruger P, Schaecken MT, Renggli HH, Fiehn W, Eickholz P (2002) Pharmacokinetic profile of a locally administered doxycycline gel in crevicular fluid, blood, and saliva. J Periodontol 73:1285–1291CrossRefPubMed

18.

Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ (2013) Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks. Clin Nutr 32:538–542CrossRefPubMed

19.

Saunders J, Naghibi M, Leach Z, Parsons C, King A, Smith T, Stroud M (2015) Taurolidine locks significantly reduce the incidence of catheter-related blood stream infections in high-risk patients on home parenteral nutrition. Eur J Clin Nutr 69:282–284CrossRefPubMed

20.

Handrup MM, Fuursted K, Funch P, Moller JK, Schroder H (2012) Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin. APMIS 120:794–801CrossRefPubMed

21.

Zwiech R, Adelt M, Chrul S (2013) A taurolidine-citrate-heparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients. Am J Ther. doi:10.1097/MJT.0b013e31828d4610

22.

Lessem J, Hanlon A (2004) A post-marketing study of 2805 patients treated for periodontal disease with Arestin. J Int Acad Periodontol 6:150–153PubMed

23.

Paquette DW, Hanlon A, Lessem J, Williams RC (2004) Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: secondary analysis of a phase 3 trial. J Periodontol 75:531–536CrossRefPubMed

24.

Matesanz-Perez P, Garcia-Gargallo M, Figuero E, Bascones-Martinez A, Sanz M, Herrera D (2013) A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 40:227–241CrossRefPubMed

25.

Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II (2006) Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50:1865–1868CrossRefPubMedPubMedCentral

26.

Shchipkova AY, Nagaraja HN, Kumar PS (2010) Subgingival microbial profiles of smokers with periodontitis. J Dent Res 89:1247–1253CrossRefPubMedPubMedCentral

27.

Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS (2010) Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8:471–480CrossRefPubMed

28.

Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322–332CrossRefPubMed

29.

Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T, Ebisu S (2003) Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol 74:1647–1651CrossRefPubMed

30.

Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA (2002) Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46:1674–1679CrossRefPubMedPubMedCentral

31.

Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S (2014) Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm. J Med Microbiol 63:284–292CrossRefPubMed

32.

Reynolds S, Moran J, Wade WG, Addy M, Newcombe R (1991) Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth. Clin Prev Dent 13:18–22PubMed

33.

Olthof ED, Nijland R, Gulich AF, Wanten GJ (2015) Microbiocidal effects of various taurolidine containing catheter lock solutions. Clin Nutr 34:309–314CrossRefPubMed

34.

Larsen T, Fiehn NE (1997) Development of resistance to metronidazole and minocycline in vitro. J Clin Periodontol 24:254–259CrossRefPubMed

35.

Nakao R, Takigawa S, Sugano N, Koshi R, Ito K, Watanabe H, Senpuku H (2011) Impact of minocycline ointment for periodontal treatment of oral bacteria. Jpn J Infect Dis 64:156–160PubMed

36.

Braumann C, Guenther N, Pohlenz J, Pfirrmann RW, Menenakos C (2009) Wound healing is not impaired in rats undergoing perioperative treatment with the antineoplastic agent taurolidine. Eur Surg Res 42:91–96CrossRefPubMed

37.

Hartel C, Scholz T, Kuhn M, Bendiks M, Gopel W, Lauten M, Herting E (2013) Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine. J Microbiol Immunol Infect 46:115–120CrossRefPubMed

Title: In vitro activity of taurolidine gel on bacteria associated with periodontitis
Authors: Sigrun Eick
Nicoletta Gloor
Cecilia Püls
Jürg Zumbrunn
Anton Sculean
Publication date: 01-04-2016
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 3/2016
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-015-1549-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

In vitro activity of taurolidine gel on bacteria associated with periodontitis

Abstract

Objectives

Methods

Results

Conclusions

Clinical relevance

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 3/2016

A temporary filling material during endodontic treatment may cause tooth fractures in two-surface class II cavities in vitro

Endodontic drug delivery for root surface disinfection: a laboratory feasibility evaluation

PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells

Immediate tooth replantation in rats: effect of systemic antibiotic therapy with amoxicillin and tetracycline

Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression

IL-17A and IL-17F polymorphisms in rheumatoid arthritis and Sjögren’s syndrome